Treatment of anxiety disorders in epilepsy: An evidence-based approach

Epilepsia

Volumn 54, Issue SUPPL. 1, 2013, Pages 13-18

  Mula, Marco ^a  

^a Division of Neurology   (Italy)

Author keywords

Antidepressant drugs; Antiepileptic drugs; Anxiety disorders; Cognitive behavioral therapy; Epilepsy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CLOMIPRAMINE; ESCITALOPRAM; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ACUTE STRESS DISORDER; AGORAPHOBIA; AMYGDALOID NUCLEUS; ANXIETY DISORDER; ARTICLE; AVOIDANCE BEHAVIOR; COGNITIVE THERAPY; COMPARATIVE EFFECTIVENESS; DISEASE CLASSIFICATION; DRUG EFFICACY; DSM-IV-TR; EPILEPSY; EVIDENCE BASED MEDICINE; FEAR; FOCAL EPILEPSY; GENERALIZED ANXIETY DISORDER; HIPPOCAMPUS; HYPOTHALAMUS; INCIDENCE; LONG TERM CARE; META ANALYSIS (TOPIC); NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATHOGENESIS; PERIAQUEDUCTAL GRAY MATTER; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL PHOBIA; SUICIDAL IDEATION; SYSTEMATIC REVIEW (TOPIC); TREATMENT RESPONSE; UNITED STATES;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; COGNITIVE THERAPY; EPILEPSY; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 84874677565     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12101     Document Type: Article

References (51)

1. Angst J, Vollrath M,. (1991) The natural history of anxiety disorders. Acta Psychiatr Scand 84: 446-452.
2. Bagby RM, Quilty LC,. (2006) Review: cognitive behavioural therapy is more effective than control and similarly effective to pharmacotherapy for generalised anxiety disorder. Evid Based Ment Health 9: 43.
3. Bakker A, van Balkom AJ, Spinhoven P,. (2002) SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand 106: 163-167.
4. Bandelow B, Seidler-Brandler U, Becker A, Wedekind D, Ruther E,. (2007a) Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry 8: 175-187.
5. Bandelow B, Wedekind D, Leon T,. (2007b) Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention. Expert Rev Neurother 7: 769-781.
6. Barry JJ, Ettinger AB, Friel P, Gilliam FG, Harden CL, Hermann B, Kanner AM, Caplan R, Plioplys S, Salpekar J, Dunn D, Austin J, Jones J,. (2008) Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 13 (Suppl. 1): S1-S29.
7. Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C,. (2010) Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 15: 850-855.
8. Blomhoff S, Haug TT, Hellstrom K, Holme I, Humble M, Madsbu HP, Wold JE,. (2001) Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry 179: 23-30.
9. Boyer W,. (1995) Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 10: 45-49.
10. Brandt C, Schoendienst M, Trentowska M, May TW, Pohlmann-Eden B, Tuschen-Caffier B, Schrecke M, Fueratsch N, Witte-Boelt K, Ebner A,. (2010) Prevalence of anxiety disorders in patients with refractory focal epilepsy-a prospective clinic based survey. Epilepsy Behav 17: 259-263.
11. Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM,. (2004) Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 61: 1005-1013.
12. De Bianchedi ET, Scalouzub De Boschan L, De Cortiñas LP, De Piccolo EG,. (1988) Theories on anxiety in Freud and Melanie Klein. Their metapsychological status. Int J Psychoanal 69 (Pt 3): 359-368.
13. Fedoroff IC, Taylor S,. (2001) Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol 21: 311-324.
14. Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC,. (2008) Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol 23: 18-28.
15. Furukawa TA, Watanabe N, Churchill R,. (2007) Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev CD004364.
16. Goodman WK,. (2004) Selecting pharmacotherapy for generalized anxiety disorder. J Clin Psychiatry 65 (Suppl. 13): 8-13.
17. Gorman JM,. (2001) Generalized anxiety disorder. Clin Cornerstone 3: 37-46.
18. Gorman JM,. (2003) Treating generalized anxiety disorder. J Clin Psychiatry 64 (Suppl. 2): 24-29.
19. Group TCCS. (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. Arch Gen Psychiatry 48: 730-738.
20. Hamid H, Ettinger AB, Mula M,. (2011) Anxiety symptoms in epilepsy: salient issues for future research. Epilepsy Behav 22: 63-68.
21. Hansen RA, Gaynes BN, Gartlehner G, Moore CG, Tiwari R, Lohr KN,. (2008) Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. Int Clin Psychopharmacol 23: 170-179.
22. Hofmann SG, Smits JA,. (2008) Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 69: 621-632.
23. Hollander E, Kaplan A, Allen A, Cartwright C,. (2000) Pharmacotherapy for obsessive-compulsive disorder. Psychiatr Clin North Am 23: 643-656.
24. Kerr MP, Mensah S, Besag F, de Toffol B, Ettinger A, Kanemoto K, Kanner A, Kemp S, Krishnamoorthy E, LaFrance WC Jr, Mula M, Schmitz B, van Elst LT, Trollor J, Wilson SJ,. (2011) International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 52: 2133-2138.
25. Krishnamoorthy ES, Trimble MR, Blumer D,. (2007) The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav 10: 349-353.
26. Ledoux JE,. (2000) Emotion circuits in the brain. Annu Rev Neurosci 23: 155-184.
27. Lindley SE, Carlson EB, Hill K,. (2007) A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol 27: 677-681.
28. Martin JL, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T, Galan C,. (2007) Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol 21: 774-782.
29. McLean CP, Asnaani A, Litz BT, Hofmann SG,. (2011) Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res 45: 1027-1035.
30. Mitte K,. (2005) Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy. Psychol Bull 131: 785-795.
31. Mueser KT, Rosenberg SD, Xie H, Jankowski MK, Bolton EE, Lu W, Hamblen JL, Rosenberg HJ, McHugo GJ, Wolfe R,. (2008) A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol 76: 259-271.
32. Mula M, Pini S, Cassano GB,. (2007) The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol 27: 263-272.
33. Mula M, Jauch R, Cavanna A, Collimedaglia L, Barbagli D, Gaus V, Kretz R, Viana M, Tota G, Israel H, Reuter U, Martus P, Cantello R, Monaco F, Schmitz B,. (2008) Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia 49: 650-656.
34. Narrow WE, Rae DS, Robins LN, Regier DA,. (2002) Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 59: 115-123.
35. Pae CU, Lim HK, Peindl K, Ajwani N, Serretti A, Patkar AA, Lee C,. (2008) The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Clin Psychopharmacol 23: 1-8.
36. Placidi GPA, Oquendo MA, Malone KM, Brodsky B, Ellis SP, Mann JJ,. (2000) Anxiety in major depression: relationship to suicide attempts. Am J Psychiatry 157: 1614-1618.
37. Rogawski MA, Loscher W,. (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10: 685-692.
38. Rosa-Alcazar AI, Sanchez-Meca J, Gomez-Conesa A, Marin-Martinez F,. (2008) Psychological treatment of obsessive-compulsive disorder: a meta-analysis. Clin Psychol Rev 28: 1310-1325.
39. Ruscio AM, Stein DJ, Chiu WT, Kessler RC,. (2010) The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 15: 53-63.
40. Schmitt R, Gazalle FK, Lima MS, Cunha A, Souza J, Kapczinski F,. (2005) The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis. Rev Bras Psiquiatr 27: 18-24.
41. Stahl SM,. (2003) Brainstorms: symptoms and circuits, part 2: anxiety disorders. J Clin Psychiatry 64: 1408-1409.
42. Stein DJ, Spadaccini E, Hollander E,. (1995) Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 10: 11-18.
43. Stein DJ, Ipser JC, Balkom AJ,. (2004) Pharmacotherapy for social phobia. Cochrane Database Syst Rev CD001206.
44. Stein DJ, Ipser JC, Seedat S,. (2006) Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev CD002795.
45. Stein DJ, Ipser JC, Baldwin DS, Bandelow B,. (2007) Treatment of obsessive-compulsive disorder. CNS Spectr 12: 28-35.
46. Stein DJ, Baldwin DS, Baldinetti F, Mandel F,. (2008) Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies. Eur Neuropsychopharmacol 18: 422-430.
47. Stein DJ, Ipser J, McAnda N,. (2009) Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines. CNS Spectr 14: 25-31.
48. Tucker P, Trautman RP, Wyatt DB, Thompson J, Wu SC, Capece JA, Rosenthal NR,. (2007) Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68: 201-206.
49. van Balkom AJ, Bakker A, Spinhoven P, Blaauw BM, Smeenk S, Ruesink B,. (1997) A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis 185: 510-516.
50. Watson HJ, Rees CS,. (2008) Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry 49: 489-498.
51. Wilkinson G, Balestrieri M, Ruggeri M, Bellantuono C,. (1991) Meta-analysis of double-blind placebo-controlled trials of antidepressants and benzodiazepines for patients with panic disorders. Psychol Med 21: 991-998.